202 related articles for article (PubMed ID: 22807266)
1. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
Velentgas P; Amato AA; Bohn RL; Chan KA; Cochrane T; Funch DP; Dashevsky I; Duddy AL; Gladowski P; Greenberg SA; Kramer JM; McMahill-Walraven C; Nakasato C; Spettell CM; Syat BL; Wahl PM; Walker AM; Zhang F; Brown JS; Platt R
Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1350-8. PubMed ID: 22807266
[TBL] [Abstract][Full Text] [Related]
2. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1120-4. PubMed ID: 17060898
[TBL] [Abstract][Full Text] [Related]
3. MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.
Cho BH; Clark TA; Messonnier NE; Ortega-Sanchez IR; Weintraub E; Messonnier ML
Vaccine; 2010 Jan; 28(3):817-22. PubMed ID: 19879992
[TBL] [Abstract][Full Text] [Related]
4. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Apr; 55(13):364-6. PubMed ID: 16601664
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
6. A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.
Velentgas P; Bohn RL; Brown JS; Chan KA; Gladowski P; Holick CN; Kramer JM; Nakasato C; Spettell CM; Walker AM; Zhang F; Platt R
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1226-34. PubMed ID: 18956428
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).
Souayah N; Yacoub HA; Khan HM; Farhad K; Mehyar LS; Maybodi L; Menkes DL; Qureshi AI
J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385
[TBL] [Abstract][Full Text] [Related]
8. Analysis of data from the CDC/FDA vaccine adverse event reporting system (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA.
Souayah N; Yacoub HA; Khan HM; Farhad K; Maybodi L; Qureshi AI; Menkes DL
J Clin Neurosci; 2012 Aug; 19(8):1089-92. PubMed ID: 22705140
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
[TBL] [Abstract][Full Text] [Related]
10. Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.
De Wals P; Deceuninck G; Boucher RM; Ouakki M
Clin Infect Dis; 2008 Apr; 46(8):e75-7. PubMed ID: 18444843
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of Guillain-Barré syndrome with vaccinations.
Baxter R; Bakshi N; Fireman B; Lewis E; Ray P; Vellozzi C; Klein NP
Clin Infect Dis; 2013 Jul; 57(2):197-204. PubMed ID: 23580737
[TBL] [Abstract][Full Text] [Related]
12. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Guillain-Barre syndrome following vaccination.
Baxter R; Lewis N; Bakshi N; Vellozzi C; Klein NP;
Clin Infect Dis; 2012 Mar; 54(6):800-4. PubMed ID: 22267712
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Oct; 54(40):1023-5. PubMed ID: 16224452
[TBL] [Abstract][Full Text] [Related]
15. Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination.
Patja A; Paunio M; Kinnunen E; Junttila O; Hovi T; Peltola H
J Pediatr; 2001 Feb; 138(2):250-4. PubMed ID: 11174624
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
17. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
[TBL] [Abstract][Full Text] [Related]
18. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome following influenza vaccination.
Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
